AB801

· Arcus Biosciences, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AB801, covering 2024-08-28 to 2026-03-31. Get the full timeline:

Most recent: Clinical Trial Update: A Study of AB801 Monotherapy and Combination Therapy in Participants With Advanced Malignancies [Phase 1]